Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol

Roos S.G. Sablerolles, Abraham Goorhuis, Corine H. GeurtsvanKessel, Rory D. de Vries, Anke L.W. Huckriede, Marion P.G. Koopmans, Melvin Lafeber, Douwe F. Postma, Debbie van Baarle, Leo G. Visser, Virgil A.S.H. Dalm, Neeltje A. Kootstra, Wim J.R. Rietdijk, P. Hugo M. van der Kuy*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
14 Downloads (Pure)
Original languageEnglish
Article number753319
JournalFrontiers in Immunology
Publication statusPublished - 24 Sept 2021

Bibliographical note

Funding Information:
The trial is funded by ZonMW in the COVID-19 program (project grantnumber: 10430072110001).

Cite this